-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Arch Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2020 to 2021.
- Arch Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -1.44 USD/shares, a 1.41% decline year-over-year.
- Arch Therapeutics, Inc. annual Earnings Per Share, Diluted for 2021 was -0.03 USD/shares, a 50% decline from 2020.
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)